
Ticasafe 90mg Tablet
Marketer
Hauz Pharma Pvt Ltd
Salt Composition
Ticagrelor (90mg)
Overview Ticasafe 90mg Tablet
CardioGuard 90mg tablets are antiplatelet agents, working to inhibit the formation of dangerous blood clots within blood vessels. This preventative action reduces the risk of stroke or heart attack in patients with existing heart conditions. CardioGuard 90mg is also indicated for post-heart attack patients, those experiencing severe angina (chest pain), and individuals who have received coronary stents. Its purpose is to mitigate the risk of recurrent heart attacks, strokes, and stent-related clotting. Concurrently, your physician will likely prescribe aspirin, another antiplatelet medication. CardioGuard 90mg may be administered with or without food, consistently at the same time daily; consistent use is crucial, even during periods of wellness. Discontinuing treatment raises the risk of cardiovascular events. The most frequent adverse effect is bleeding, potentially prolonging bleeding time from injuries. While typically mild and self-limiting, persistent bleeding should be reported. Some patients experience mild shortness of breath, usually resolving with continued therapy; worsening or persistent shortness of breath requires medical attention. CardioGuard 90mg is contraindicated in individuals with active internal bleeding (e.g., ulcers, cerebral hemorrhage) or liver disease. Consult your physician prior to use if you have any such conditions.
Uses of Ticasafe 90mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Ticasafe 90mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 90mg Ticasafe tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Ticasafe 90mg Tablet:
- Bleeding
- Breathlessness
How to use Ticasafe 90mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Ticasafe 90mg Tablets can be consumed with or without food, however, consistent daily timing is preferable.
How Ticasafe 90mg Tablet works:
Aggrenox 90mg tablets are antithrombotic agents. Their mechanism of action involves inhibiting platelet aggregation, thus reducing the risk of dangerous blood clot development. This subsequently minimizes the likelihood of cardiovascular events such as stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Ticasafe 90mg Tablet with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Pregnant women should exercise caution when considering Ticasafe 90mg tablets. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the risks and advantages before prescribing this medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of 90mg Ticasafe tablets with breastfeeding is currently unavailable. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Ticasafe 90mg Tablets.
KidneySAFE IF PRESCRIBED
Ticasafe 90mg tablets are considered safe for individuals with impaired kidney function, requiring no dosage modification. Data on Ticasafe 90mg tablet use in patients undergoing renal dialysis is currently scarce.
LiverCAUTION
Patients with liver impairment should use Ticasafe 90mg tablets cautiously, potentially requiring dosage modification. Severe hepatic dysfunction contraindicates the use of Ticasafe 90mg tablets; physician consultation is advised.
What if you forget to take Ticasafe 90mg Tablet :
Should you forget a dose of Ticasafe 90mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ticasafe 90mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Triazolopyrimidine derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | ADP receptor antagonists (P2Y12 inhibitors) |
